YVONNE ALEXANDER: Open Payments
NPI 1043757164 · SULPHUR, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$364 in 20 payments from 8 companies in 2025. Trend: 2023 $149 · 2024 $422 · 2025 $364
Food & beverage: $364
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $163 |
| ABBVIE INC. | 3 | $60 |
| Exact Sciences Corporation | 2 | $42 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
| Novo Nordisk Inc | 1 | $22 |
| Gilead Sciences, Inc. | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $14 |
Products named: CAPLYTA, VRAYLAR, The Cologuard Plus Collection Kit, AIRSUPRA, Qelbree, NEXLETOL.
Industry payments across LA — which companies pay providers there.
